Announcement
03 Dec 2020
In December 2020, the Norwegian authorities introduced an export ban on certain rivaroxaban, certain immunoglobulins and formoterol & budesonide following the outbreak of COVID-19.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
03 Dec 2020
Revocation date:
28 Jan 2021
On 3 December 2020, the Norwegian Medicines Agency introduced an export ban on rivaroxaban (20mg, 28pcs), immunoglobulins (IOVIG 100MG/ML, 300 ml hgl) and formoterol & budesonide. The export ban wa...
See all
This state act is not part of any Thread yet.